Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CEFOXITIN FOR INJECTION USP DIN 02291738

Status: Cancelled Post Market
Holder: PFIZER CANADA ULC
Molecule: CEFOXITIN (CEFOXITIN SODIUM)

Health Canada record

Active ingredient(s)CEFOXITIN (CEFOXITIN SODIUM) 2 G
Dosage formPowder For Solution
RouteIntravenous; Intramuscular
SchedulePRESCRIPTION
ClassHuman
ATCJ01DC01 CEFOXITIN
Original market date21-Dec-2007
Current status date28-Jun-2019
SourceHealth Canada DPD

Establishment licence of the holder

Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CEFOXITIN (CEFOXITIN SODIUM)

DINProductCompanyFormStrengthStatus
02128195CEFOXITIN FOR INJECTIONTEVA CANADA LIMITEDPowder For SolutionCEFOXITIN (CEFOXITIN SODIUM) 2 GMarketed
02128187CEFOXITIN FOR INJECTIONTEVA CANADA LIMITEDPowder For SolutionCEFOXITIN (CEFOXITIN SODIUM) 1 GMarketed
02240773CEFOXITIN FOR INJECTIONTEVA CANADA LIMITEDPowder For SolutionCEFOXITIN (CEFOXITIN SODIUM) 10 GCancelled Post Market
02291711CEFOXITIN FOR INJECTION USPPFIZER CANADA ULCPowder For SolutionCEFOXITIN (CEFOXITIN SODIUM) 1 GCancelled Post Market
00893668MEFOXIN INJ 1GM/VIAL ADD-VANTAGMERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.Powder For SolutionCEFOXITIN (CEFOXITIN SODIUM) 1 GCancelled Post Market
00893676MEFOXIN INJ 2GM/VIAL ADD-VANTAGMERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.Powder For SolutionCEFOXITIN (CEFOXITIN SODIUM) 2 GCancelled Post Market
00663697MEFOXIN PWS 1GM/VIALMERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.Powder For SolutionCEFOXITIN (CEFOXITIN SODIUM) 1 GCancelled Post Market
00663700MEFOXIN PWS 2GM/VIALMERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.Powder For SolutionCEFOXITIN (CEFOXITIN SODIUM) 2 GCancelled Post Market
01980653MEFOXIN PWS INJ 10GM/VIALMERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.Powder For SolutionCEFOXITIN (CEFOXITIN SODIUM) 10 GCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
208682018-05-16Abbreviated New Drug Submission (ANDS)MERGER - BUYOUT
117022010-09-01Abbreviated New Drug Submission (ANDS)Manufacturer name change
89212007-07-20Supplement to an Abbreviated New Drug Submission (SANDS)CHANGE TO VIAL LABELS AND PRODUCT NAME CHANGE
85692007-02-05Abbreviated New Drug Submission (ANDS)
Request a quote for CEFOXITIN FOR INJECTION USP

How to read a Canadian DIN record